Literature DB >> 32875054

Cerebrovascular medin is associated with Alzheimer's disease and vascular dementia.

Raymond Q Migrino1,2, Nina Karamanova1, Seth Truran1, Geidy E Serrano3, Hannah A Davies4, Jillian Madine4, Thomas G Beach3.   

Abstract

INTRODUCTION: Medin, an aging-associated amyloidogenic protein, induces cerebrovascular dysfunction and inflammation. We investigated the relationship between cerebrovascular medin and Alzheimer's disease (AD) and vascular dementia (VaD).
METHODS: Cerebral arteriole medin was quantified from 91 brain donors with no dementia (ND), AD, VaD, or combined AD and VaD. Correlation analyses evaluated the relationship between arteriole medin, and plaques, tangles, or white matter lesions (WML). Receiver operating characteristic and regression analyses assessed whether medin is predictive of AD or VaD versus other cerebrovascular pathologies (circle of Willis [CoW] atherosclerosis and cerebral amyloid angiopathy [CAA]).
RESULTS: Arteriole medin was higher in those with AD, VaD, or combined AD/VaD versus ND (P < .05), and correlated with tangle, plaque, and WML, but not CAA or CoW atherosclerosis. Among cerebrovascular pathologies, medin was the strongest predictor of AD diagnosis, whereas CoW atherosclerosis and arteriole medin were predictors of VaD. DISCUSSION: Cerebral arteriole medin is associated with and could be a potential novel risk factor or biomarker for AD and VaD.
© 2020 the Alzheimer's Association.

Entities:  

Keywords:  Alzheimer's disease; aging; amyloid; cerebrovascular disease; dementia; medin; vascular dementia

Year:  2020        PMID: 32875054      PMCID: PMC7447901          DOI: 10.1002/dad2.12072

Source DB:  PubMed          Journal:  Alzheimers Dement (Amst)        ISSN: 2352-8729


  41 in total

1.  Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections.

Authors:  H Braak; E Braak
Journal:  Brain Pathol       Date:  1991-04       Impact factor: 6.508

2.  Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease.

Authors:  B T Hyman; J Q Trojanowski
Journal:  J Neuropathol Exp Neurol       Date:  1997-10       Impact factor: 3.685

3.  Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain.

Authors:  Paula Grammas; Roma Ovase
Journal:  Am J Pathol       Date:  2002-05       Impact factor: 4.307

Review 4.  Mechanisms underlying inflammation in neurodegeneration.

Authors:  Christopher K Glass; Kaoru Saijo; Beate Winner; Maria Carolina Marchetto; Fred H Gage
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 5.  Alzheimer disease as a vascular disorder: nosological evidence.

Authors:  J C de la Torre
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

6.  Circle of willis atherosclerosis is a risk factor for sporadic Alzheimer's disease.

Authors:  Alex E Roher; Chera Esh; Tyler A Kokjohn; Walter Kalback; Dean C Luehrs; James D Seward; Lucia I Sue; Thomas G Beach
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-09-25       Impact factor: 8.311

7.  Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Authors:  Sun-Ah Choi; Virgilio Gerald Hilario Evidente; John N Caviness; Holly A Shill; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2009-12-03       Impact factor: 17.088

Review 8.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

9.  Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia.

Authors:  Raymond Q Migrino; Seth Truran; Nina Karamanova; Geidy E Serrano; Calvin Madrigal; Hannah A Davies; Jillian Madine; Peter Reaven; Thomas G Beach
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

10.  Idiopathic degenerative thoracic aneurysms are associated with increased aortic medial amyloid.

Authors:  Hannah A Davies; Eva Caamaño-Gutiérrez; Ya Hua Chim; Mark Field; Omar Nawaytou; Lorenzo Ressel; Riaz Akhtar; Jillian Madine
Journal:  Amyloid       Date:  2019-06-18       Impact factor: 7.141

View more
  5 in total

Review 1.  Age-associated proinflammatory elastic fiber remodeling in large arteries.

Authors:  Soo Hyuk Kim; Robert E Monticone; Kimberly R McGraw; Mingyi Wang
Journal:  Mech Ageing Dev       Date:  2021-04-08       Impact factor: 5.498

Review 2.  Inflammation, Nitro-Oxidative Stress, Impaired Autophagy, and Insulin Resistance as a Mechanistic Convergence Between Arterial Stiffness and Alzheimer's Disease.

Authors:  Jhana O Hendrickx; Wim Martinet; Debby Van Dam; Guido R Y De Meyer
Journal:  Front Mol Biosci       Date:  2021-03-29

3.  Dangerous Stops: Nonsense Mutations Can Dramatically Increase Frequency of Prion Conversion.

Authors:  Alexander A Dergalev; Valery N Urakov; Michael O Agaphonov; Alexander I Alexandrov; Vitaly V Kushnirov
Journal:  Int J Mol Sci       Date:  2021-02-03       Impact factor: 5.923

4.  MFG-E8 (LACTADHERIN): a novel marker associated with cerebral amyloid angiopathy.

Authors:  Paula Marazuela; Montse Solé; Anna Bonaterra-Pastra; Jesús Pizarro; Jessica Camacho; Elena Martínez-Sáez; H Bea Kuiperij; Marcel M Verbeek; Anna M de Kort; Floris H B M Schreuder; Catharina J M Klijn; Laura Castillo-Ribelles; Olalla Pancorbo; David Rodríguez-Luna; Francesc Pujadas; Pilar Delgado; Mar Hernández-Guillamon
Journal:  Acta Neuropathol Commun       Date:  2021-09-16       Impact factor: 7.801

5.  Increased MFG-E8 at neuromuscular junctions is an exacerbating factor for sarcopenia-associated denervation.

Authors:  Madoka Ikemoto-Uezumi; Heying Zhou; Tamaki Kurosawa; Yuki Yoshimoto; Masashi Toyoda; Nobuo Kanazawa; Tatsu Nakazawa; Mitsuhiro Morita; Kunihiro Tsuchida; Akiyoshi Uezumi
Journal:  Aging Cell       Date:  2021-12-24       Impact factor: 9.304

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.